Effect of obesity on the outcome of kidney transplantation: A 20-year follow-up

Transplantation

Volumn 91, Issue 8, 2011, Pages 869-874

  Hoogeveen, Ellen K ^a,b   Aalten, Jeroen ^c   Rothman, Kenneth J ^d   Roodnat, Joke I ^e   Mallat, Marko J K ^a   Borm, George ^c   Weimar, Willem ^e   Hoitsma, Andries J ^c   De Fijter, Johan W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RTI HEALTH SOLUTIONS   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Epidemiology; Graft failure; Kidney transplantation; Mortality; Obesity

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NETHERLANDS; OBESITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79954884826     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182100f3a     Document Type: Article

References (31)

1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to1996. N Engl J Med 2000; 342: 605.
2. Pascual M, Theruvath T, Kawai T, et al. Strategies to improve longterm outcomes after renal transplantation.NEngl J Med 2002; 346: 580.
3. Armstrong KA, Campbell SB, Hawley CM, et al. Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant 2005; 5: 2710.
4. Foster MC, Hwang SJ, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis 2008; 52: 39.
5. Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21.
6. Praga M. Obesity-A neglected culprit in renal disease. Nephrol Dial Transplant 2002; 17: 1157.
7. Report of aWHOConsultation. Obesity: Preventing and managing the global epidemic. World Health Organ Tech Rep Ser 2000; 894: 1.
8. Aalten J, Christiaans MH, de Fijter JW, et al. The influence of obesity on short- and long-term graft and patient survival after renal transplantation. Transpl Int 2006; 19: 901.
9. Friedman AN, Miskulin DC, Rosenberg IH, et al. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 2003; 41: 480.
10. Gore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal transplantation. Am J Transplant 2006; 6: 357.
11. Segev DL, Simpkins CE, Thompson RE, et al. Obesity impacts access to kidney transplantation. J Am Soc Nephrol 2008; 19: 349.
12. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation 2002; 73: 70.
13. Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293: 1861.
14. Ghahramani N, Reeves WB, Hollenbeak C. Association between increased body mass index, calcineurin inhibitor use, and renal graft survival. Exp Clin Transplant 2008; 3: 199.
15. Massarweh NN, Clayton JL, Mangum CA, et al. High body mass index and short- and long-term renal allograft survival in adults. Transplantation 2005; 80: 1430.
16. Howard RJ, Thai VB, Patton PR, et al. Obesity does not portend a bad outcome for kidney transplant recipients. Transplantation 2002; 73: 53.
17. Chagnac A, Herman M, Zingerman B, et al. Obesity-induced glomerular hyperfiltration: Its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 2008; 23: 3946.
18. Zocalli C, Mallamaci F. Obesity, diabetes, adiponectin and the kidney: A podocyte affair. Nephrol Dial Transplant 2008; 23: 3767.
19. Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001; 16: 1790.
20. Chen HM, Liu ZH, Zeng CH, et al. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis 2006; 48: 772.
21. Han SY, Kang YS, Jee YH, et al. High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes. Cell Tissue Res 2006; 323: 321.
22. Manson JE, Stampfer MJ, Hennekens CH, et al. Body weight and longevity. A reassessment. JAMA 1987; 257: 353.
23. Rettkowski O, Wienke A, Hamza A, et al. Low body mass index in kidney transplant recipients: Risk or advantage for long-term graft function? Transplant Proc 2007; 39: 1416.
24. Chang SH, Coates PTH, McDonald SP. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation 2007; 84: 981.
25. Kalanter-Zadeh K, Ikizler TA, Block G, et al. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis 2003; 42: 864.
26. Reynolds SL, Saito Y, Crimmins EM. The impact of obesity on active life expectancy in older American men and women. Gerontologist 2005; 45: 438.
27. Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes 2008; 32: S56.
28. Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation 2007; 115: 2111.
29. Rothman KJ, Greenland S. Modern epidemiology [ed. 2]. Philadelphia, Lippincott-Raven 1998, p 115.
30. Aalten J, Hoogeveen EK, Roodnat JI, et al. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death. Transpl Int 2008; 21: 985.
31. Moons KG, Donders RA, Stijnen T, et al. Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol 2006; 59: 1092.